Skip to content

?Effect of periodontal treatment on the level of serum inflammatory biomarkers

Effect of periodontal treatment on the C-reactive protein, plasma fibrinogen and white blood cell count in advanced periodontitis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138706031081N1
Enrollment
32
Registered
2009-01-04
Start date
2007-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Serum biomarkers in periodontal therapy. Chronic periodontitis

Interventions

Standard non-surgical periodontal therapy within two appointments including scaling and root planning with simultaneous lavage of chlorhexidine 0.1% from the tip of ultrasonic instrument into the pock
Treatment - Drugs

Sponsors

Guilan Universoty of Medical Sciences, Pro-vice-chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 56 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Being systemically healthy, No history of previous periodontal therapy and antibiotic use during the past three months, Body mass index between 20-27, Existence of at least 20 standing teeth without untreated periapical lesions, At least 15% of sites with more than or equal to 5 mm of clinical attachment loss and pocket depth. Radiographic evidence of bone loss Exclusion criteria: Drugs such as: anticoagulants, steroids, anti-inflammatory drugs, immunosuppressant drugs, statins. Systemic diseases or conditions such as: Arthritis, GI disorders, skin diseases, bronchitis, Diabetes Mellitus, pregnancy, breast feeding and smoking.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum CRP levels. Timepoint: Before and four months after the intervention. Method of measurement: hs-CRP, by Enzyme- linked immunosorbent assay(ELIZA).;Plasma fibrinogen levels. Timepoint: Before and four months after the intervention. Method of measurement: Digital coagulation technique.;White blood cell counts. Timepoint: Before and four months after the intervention. Method of measurement: Counts in the peripheral blood samples.

Secondary

MeasureTime frame
Probing pocket depth. Timepoint: Before and four months after intervention. Method of measurement: Williams periodontal probe calibrated in millimeters with probe tip of 0.4 mm in width.;Clinical Attachment Level. Timepoint: Before and four months after the intervention. Method of measurement: Williams periodontal probe calibrated in millimiters with a probe tip of 0.4mm width.;Plaque index scores. Timepoint: Before and four months after intervention. Method of measurement: Plaque index OLeary.;Gingival index. Timepoint: Before and four months after intervention. Method of measurement: Lenox & Kopezyk bleeding points index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGolpar Radafshar

Guilan University of Medical Sciences, School of Dentistry

golshad@gums.ac.ir+98 131 3230775 +98 131 3220060

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026